Clinical trial
Molecular Markes of Fibrosis of Single Types of Endometriosis and Their Use in Predicting Disease Severity
NCT06020482 is registered in ClinicalTrials.gov with General University Hospital, Prague as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Markes of Fibrosis of Single Types of Endometriosis and Their Use in Predicting Disease Severity
- Lead sponsor
- General University Hospital, Prague
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 1, 2023
- Completion date
- December 31, 2026
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
molecular markers of fibrosis of single types of endometriosis and their use in predicting disease severity